Hoffmann-La Roche, Inc. Amber L. Morris, Emron Awwal and Karl Bruce Frank,
Fa2N-4 cells performed much like fresh human hepatocytes. These immortalized cells have potential for use as an alternative to primary human liver tissue for In Vitro Induction Studies.
Ronald Faris, Ph.D., CSO, MultiCell Technologies, Inc. We believe that MultiCell’s liver cell lines will rapidly become the gold standard throughout the pharmaceutical industry for testing of new drugs,” Faris said. “Our customers have been very pleased with the initial deliveries and we expect to see a ramp up of revenues as our cell lines become more integrated into their drug discovery processes.”
Edward T. Maggio, Ph.D, CEO, Cengent Therapeutics Inc.
This technology promises to increase the efficiency of drug discovery and save many millions of dollars by reducing the ultimate failure rate in clinical trials, benefiting both drug companies and consumers alike.”
Dr. Andrew Parkinson, CEO, XenoTech LLC
“MCT’s cell lines represent a breakthrough technology that has the potential to revolutionize how the pharmaceutical industry screens new drug entities, we anticipate significant worldwide interest in MCT’s cell lines.”
J.B. Mills, and S. .M. de Morais, Pfizer Global Research & Development
We investigated the use of a novel human hepatocyte clone [Fa2N-4] as an alternative reagent, which is readily available and provides a consistent, reproducible system.
These data show that use of Fa2N-4 cells in conjunction with the Invader® technology is a potential high-throughput in-vitro method for assessment of induction of ADMET targets.
Ann Randolph, Managing Director of BIOCOM (1993-1999)
“Exten is one of the most exciting companies I have seen. MultiCell’s immortalized liver cell technology platform offers enormous potential in a variety of critical markets. This company should grow rapidly and I am happy to be a part of this fine organization.”
Jerry Newmin, CEO, Exten Industries
“We are confident that sales in even a small percent of the drug discovery and toxicology testing arena will contribute significant revenues.
AI
